Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, destructiveHint=false. The description goes far beyond that by explaining the multi-source fan-out, soft-failure for patents (USPTO sunset), expected empty sections (e.g., fda_products for small-molecule-only companies), sources_used/sources_failed semantics, name resolution via EDGAR, and behavior for private companies (resolved:false with notes). This rich context helps the agent handle edge cases correctly.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but every sentence adds critical operational detail: trigger examples, the preference rule, the exhaustive list of return sections with caveats, and failure handling. It is front-loaded with usage triggers and then logically organized. While it could be tightened slightly, the length is justified by the tool's complexity and the lack of an output schema.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description must fully explain the return structure—and it does. Each section (recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI) is described with examples and expected behavior. It covers parameter handling, resolution, failures, and even the meaning of sources_used/sources_failed. Nothing an agent needs to invoke the tool correctly is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema already describes both parameters with 100% coverage (type enum with explanation, value with examples). The description adds value by reinforcing that type accepts 'company' or 'ticker' interchangeably and that value can be a ticker, CIK, or name, and explaining resolution behavior. It reiterates schema content but provides additional edge-case context (e.g., zero-padded CIK, private company resolution).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states that the tool returns a full cross-source profile of a US public company in one call, enumerating the data sources (SEC EDGAR, XBRL, USPTO, USAspending, etc.) and the specific return sections (cik, recent_filings, fundamentals, patents, etc.). It clearly distinguishes this from sibling tools like compare_entities (which compares multiple entities) and deep_research (which is broader research), making its purpose unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides strong positive guidance: trigger phrases ('Tell me about X', 'research Acme') and an explicit preference statement ('ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups') for holistic views. However, it does not directly compare against sibling tools like deep_research or compare_entities, leaving the agent to infer when this should be chosen over those alternatives for a holistic request.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Most tools have clearly differentiated roles, but several pairs blur boundaries: ask_pipeworx and ask_pipeworx_beta are currently functionally identical, and identify vs resolve both wrap the same NCI CACTUS service. The detailed descriptions rescue most selections, but an agent could easily mispick between the research and chemical lookup options.

Naming Consistency3/5

Names are mostly snake_case and readable, but conventions are mixed: some are verb-first (ask_pipeworx, validate_claim, search_within) while many are noun-first or domain-prefixed (entity_profile, polymarket_edges, recent_changes, pipeworx_trending). There is no single predictable pattern for a new tool's name, though subfamilies (polymarket_*, ask_pipeworx_*) are internally consistent.

Tool Count3/5

At 33 tools, this is well above the typical well-scoped range and carries real selection overhead. The unusually broad purpose—a data router plus prediction-market analysis, memory, subscriptions, and several standalone utilities—partially justifies the count, but it still feels heavy and could be consolidated.

Completeness4/5

For its varied subdomains, coverage is strong: memory has remember/recall/forget, subscriptions have subscribe/unsubscribe/list/recent_alerts, and prediction markets span research, edge scanning, arbitrage, fill-risk, and edge telemetry. Minor gaps exist—such as no direct tool to fetch a specific citation URI by identifier, and the redundant stable/beta router pair—but there are no obvious dead ends.